Search Within

Computational Oncology Service

  1. "Urology"
Formats
  1. Journal Article (66)
  2. Meeting Abstract (35)
  3. Editorial (3)
  4. Review (3)
Groups
  1. Epidemiology and Biostatistics (107)
  2. Surgery (107)
  3. Urology (107)
  4. GSK Faculty (106)
  5. Human Oncology and Pathogenesis Program (105)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (95)

More Groups

People
  1. Abraham Hakimi (70)
  2. Eduard Reznik (56)
  3. Nikolaus Schultz (53)
  4. Paul Russo (40)
  5. Victor Reuter (38)
  6. Jonathan Coleman (37)

More People

Years
  1. 2025 (4)
  2. 2024 (10)
  3. 2023 (8)
  4. 2022 (8)
  5. 2021 (10)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. Clinical Cancer Research (10)
  3. European Urology (10)
  4. European Urology Focus (6)
  5. Urologic Oncology: Seminars and Original Investigations (5)
  6. BJU International (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. American Association for Cancer Research (17)
  3. Elsevier Science, Inc. (11)
  4. Nature Publishing Group (11)
  5. Elsevier Inc. (9)
  6. Cell Press (8)

More Publishers

Results (107)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association between clonal hematopoiesis and survival after nephrectomy in patients with renal cell carcinoma
    Meeting Abstract

    Khandwala, Y.; Ruthen, N.; Kotecha, R. R.; Russo, P.; Coleman, J.; Reznik, E.; Hakimi, A. A.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors
    Journal Article

    Khaleel, S.; Perera, M.; Papa, N.; Kuo, F.; Golkaram, M.; Rappold, P.; Kotecha, R. R.; Coleman, J.; Russo, P.; Motzer, R.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Molecular heterogeneity and immune infiltration drive clinical outcomes in upper tract urothelial carcinoma
    Journal Article

    Kim, K.; Alam, S. M.; Kuo, F.; Chen, Z.; Yip, W.; Katims, A. B.; Chu, C.; Lenis, A. T.; Hu, W.; Gokturk Ozcan, G.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Sample site impacts RNA biomarkers for renal cell carcinoma
    Journal Article

    Eismann, L.; Xie, A. X.; Tang, C.; Knezevic, A.; Ostrovnaya, I.; Kuo, F.; Ari Hakimi, A.; Reznik, E.; Kotecha, R. R.
    European Urology (2025)

    Fulltext@MSK | Save
  • Obesity-dependent selection of driver mutations in cancer
    Journal Article

    Tang, C.; Castillon, V. J.; Waters, M.; Fong, C.; Park, T.; Boscenco, S.; Kim, S.; Pekala, K.; Carrot-Zhang, J.; Hakimi, A. A.; more...
    Nature Genetics (2024)

    Fulltext@MSK | Save
  • Node positive non-clear cell renal cell carcinoma: Oncological outcomes and genomic insights
    Meeting Abstract

    Eismann, L.; Zucker, M.; Dawidek, M.; Reese, S.; Posada Calderon, L.; Aulitzky, A.; Stief, C.; Coleman, J.; Kotecha, R.; Carlo, M.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Microsatellite instability, tumor mutational burden, and response to immune checkpoint blockade in patients with prostate cancer
    Journal Article

    Lenis, A. T.; Ravichandran, V.; Brown, S.; Alam, S. M.; Katims, A.; Truong, H.; Reisz, P. A.; Vasselman, S.; Nweji, B.; Autio, K. A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • PAK4-targeted PROTACs in clear cell renal cell carcinoma: A two-for-one targeted and immune therapy?
    Editorial

    Bakouny, Z.; Braun, D. A.; Reznik, E.; Hakimi, A. A.
    EBioMedicine (2024)

    Fulltext@MSK | Save
  • The NF-I/a transcription factor is a HIF-independent oncogenic dependency in kidney cancer
    Meeting Abstract

    Scovell, J.; Zayas, S.; Grubb, T.; Kuo, F.; Reznik, E.; Hakimi, A. A.; Chakraborty, A.
    Journal of the National Comprehensive Cancer Network (2024)

    Fulltext@MSK | Save